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During the early stages of embryogenesis, pluripotent neural crest cells (NCC) are known to migrate from the neural folds to popu-
late multiple target sites in the embryo where they diﬀerentiate into various derivatives, including cartilage, bone, connective tissue,
melanocytes, glia, and neurons of the peripheral nervous system. The ability to obtain pure NCC populations is essential to enable
molecular analyses of neural crest induction, migration, and/or diﬀerentiation. Crossing Wnt1-Cre and Z/EG transgenic mouse
lines resulted in oﬀspring in which the Wnt1-Cre transgene activated permanent EGFP expression only in NCC. The present report
demonstratesaﬂowcytometricmethodtosortandisolatepopulationsofEGFP-labeledNCC.Theidentityofthesortedneuralcrest
cells was conﬁrmed by assaying expression of known marker genes by TaqMan Quantitative Real-Time Polymerase Chain Reaction
(QRT-PCR).ThemolecularstrategydescribedinthisreportprovidesameanstoextractintactRNAfromapurepopulationofNCC
thus enabling analysis of gene expression in a deﬁned population of embryonic precursor cells critical to development.
INTRODUCTION
Cranial neural crest cells (NCC) represent an impor-
tant population of progenitor cells that arise from the
neural folds of the posterior midbrain and hindbrain and
migrate into the branchial arches where they diﬀerentiate
intoconnectivetissueandskeletalcomponentsoftheneck
and craniofacial region, melanocytes, and certain sensory
ganglia of the nervous system. Several defects in embry-
onic craniofacial development have been attributed to ab-
normalities in NCC formation, proliferation, and/or mi-
gration [1, 2]. Induction, proliferation, and migration of
NCC have been shown to be under the control of a num-
ber of signal transduction pathways [3, 4, 5, 6]. Exper-
imental strategies that have been utilized to investigate
NCCfunctionincludetheuseofchick-quailchimeras[3],
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cell labeling with vital dyes [7, 8], NCC-speciﬁc antibod-
ies [9], and retroviral-mediated gene transfer [10]. While
these approaches have been exceedingly useful in reveal-
ing much of what is known regarding NCC function at
the cellular level, the inability to isolate pure populations
of NCC for genomic or proteomic analysis has, until now,
presented a signiﬁcant barrier to a fuller appreciation of
NCC function during craniofacial morphogenesis.
Using a novel two-component mouse model system,
the NCC of the developing embryo have been perma-
nently and genetically labeled with enhanced green ﬂu-
orescent protein (EGFP) [11]. The method involves ac-
tivation of green ﬂuorescent protein transgene expres-
sion by Wnt1-promoter-directed Cre-recombinase. Wnt1
is a protooncogene encoding an intracellular signaling
molecule that is temporally expressed in the developing
midbrain [12, 13]. The cranial NCC arise from Wnt1-
expessingcellsinthecentralnervoussystem.Thus,theex-
pression of Wnt1 is a useful marker for cranial NCC. Re-
cent studies have reported the construction of Wnt1-Cre
transgenes [14]. Others have reported Wnt1-activation
of a reporter gene by Cre recombinase [15]. Novak et al
[16] have reported tissue speciﬁc activation of the EGFP-
transgene by the Cre/LoxP recombinase system. Taking
advantage of these reports, we have crossed a Wnt1-
Cre transgenic mouse strain with the Z/EG transgenic2005:3 (2005) Novel Method to Isolate Pure Neural Crest Cells and Extract RNA 233
reporter line in which EGFP is only expressed in the pres-
ence of Cre-recombinase. This resulted in oﬀspring in
which the Wnt1-Cre transgene permanently and genet-
ically activated EGFP expression only in the NCC. This
enables precise delineation of NCC formation, migration,
andsubsequentcellulardiﬀerentiation,aswellasallowing
extraction of RNA for gene expression studies [11].
The development of EGFP as an intracellular vi-
tal reporter has made feasible ﬂow cytometric separa-
tion of labeled cells for analysis of gene expression [17].
Fluorescence-activated cell sorting (FACS) is a ﬂow cyto-
metric method commonly used to isolate discrete popu-
lations of cells from heterogeneous cell pools. The tech-
nique of cell sorting derives from the principle that
ﬂuid streams in air are unstable and decay into spher-
ical droplets as a consequence of reduction in free en-
ergy. Application of a voltage to the ﬂuid stream at
this time imposes a corresponding charge on the sur-
face of the newly formed droplet. In the present study,
this charge was provided by EGFP expressed by the NCC.
The charged droplet can thus be deﬂected and separated
during its passage through a ﬁxed high-voltage electro-
static ﬁeld. As this process of ﬂuid charging can be rapidly
and reversibly switched, high rates of cell sorting can
be readily achieved. In order to conﬁrm that the ﬂow
sorting methodology employed did indeed isolate EGFP-
labeledneuralcrestcells,expressionofNCCmarkergenes
Crabp1, Slug, Msx1, and Dlx5 by the sorted cells was an-
alyzed by TaqMan quantitative real time PCR. [18, 19].
Additionally, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) was utilized as an internal control [20], while
expression of En1 (encoding the mouse homeodomain
protein, engrailed-1) was examined as a negative control.
En1 is expressed in the embryonic midbrain/hindbrain
region, but not in NCC [21]. The present report elab-
orates a powerful tool to genetically and indelibly label
and isolate multipotent cranial NCC. This approach en-
sures that the integrity of the genetic material, particu-
larly RNA, remains high and enables precise genomic and
proteomic analysis of the fate and function of the mam-
malianneuralcrestduringthecourseofembryonicdevel-
opment.
MATERIALS AND METHODS
BreedingofWnt-CreXZ/EGtransgenicmousestrains
Both the Wnt1-Cre transgenic mouse line (pro-
vided by Dr Andrew McMahon, Harvard University,
Cambridge, Mass) and the Z/EG transgenic mouse line
(Tg [ACTB-Bgeo/GFP] 21Lbe), (Jackson Laboratory, Bar
Harbor, Me) have been described previously [14, 16].
The animals were maintained on a light-dark cycle with
light from 0600 to 1800 hours. Mating Wnt1-Cre+/− with
Z/EG+/− mice generated Wnt1-Cre/Z/EG double trans-
genic mice. Embryonic age was determined based on
the time of detection of a vaginal plug, with noon of
that day being considered as 0.5dpc (days post coition).
Genotypes of the double transgenic embryos were deter-
mined by PCR [14, 16] using genomic DNA isolated from
individual embryonic yolk sacs.
VisualizationofEGFP-labeledNCC
EGFP-labeled NCC were visualized in intact embryos
usingaNikonSMZ1500stereomicroscopeequippedwith
epiﬂuorescenceoptics(470–490nm[excitation]and525–
550nm [emission]), and photographed using a Nikon
DXM 1200 digital camera.
Fluorescence-activatedcellsorting(FACS)
Embryos, 9.5dpc, were dissected in ice-cold calcium-
magnesium-free phosphate-buﬀered saline (CMF-PBS)
(per liter: 0.2g K Cl, 0.2g KH 2PO4,8 .0g NaCl, 2.16g
Na2HPO4.7H2O, pH 7.2 )a n dh e a d sr e m o v e da b o v et h e
second branchial arch. Following removal of the mid-
brainandhindbrain,theremainingtissue,comprisingthe
frontonasal region and the ﬁrst branchial arch, was incu-
bated with 1.5mL(0.5%) trypsin at 37 ◦Cf o r1 0m i n u t e s
followed by pelleting and resuspension in tissue culture
medium with 5% fetal bovine serum (FBS). Cell sorting
was performed using a Mo-Flo DakoCytomation (Fort
Collins, Colo) equipped with an Omnichrome series 43
air-cooled 488nm argon laser at 100mW of power. For-
ward scatter (FS) and side scatter (SSC) were collected
through a ﬁlter. The EGFP signal was collected in the
FL1 channel through a 530/40 bandpass ﬁlter. A light
scatter gate was drawn in the SSC versus FS plot to ex-
clude debris and include the viable ES cells. Cells in the
gate were displayed in a single-parameter histogram for
the EGFP and ﬁnal gating settings determined to col-
lect the labeled cells. Post-sorting, the cells were col-
lected in tissue culture medium with 5% FBS and plated
in 4 well-chambered slides (LabTek, Nalge Nunc Inter-
national, Naperville, Ill) at a concentration of 50000
cells/well. Cells were photographed at 115 times magni-
ﬁcation on a Nikon Eclipse TE2000U inverted-phase con-
trastmicroscopewithepiﬂuorescenceopticsusingaDXM
1200 digital camera.
TotalRNAisolationandproductionofantisenseRNA
Cells isolated by FACS (approximately 5000) were col-
lected in microcentrifuge tubes and processed using the
PicoPure RNA isolation kit (Arcturus, Mountain View,
Calif) according to the manufacturer’s protocol. Brieﬂy,
11µLv o l u m eo fe x t r a c t i o nb u ﬀer was placed into the mi-
crocentrifuge tube containing the sorted cells and incu-
bated for 30 minutes at 42 ◦C . After incubation, the cell
lysate was loaded onto a spin column, washed, and to-
tal cellular RNA was eluted in a 10µLv o l u m eo fe l u t i o n
buﬀer. One µL of total RNA was used as template to pro-
duce antisense RNA (aRNA) using the RiboAmp kit (Arc-
turus) following manufacturer’s instructions.
RNA ampliﬁcation was achieved by two rounds of
ﬁrst-strandcDNAsynthesis,second-strandcDNAsynthe-
sis, and in vitro transcription. The quality of resultant234 Saurabh Singh et al 2005:3 (2005)
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Figure 1. (Top) EGFP-labeled NCC in Wnt1-Cre/Z/EG transgenic mouse embryos. Photomicrograph of a 9.5-dpc, two-component
Wnt1-Cre/Z/EG transgenic embryo (right) adjacent to a wildtype littermate (left) under darkﬁeld optics (a) and epiﬂuorescence
optics (b). (c) A 9.5-dpc, two-component Wnt1-Cre/Z/EG transgenic embryo photographed under epiﬂuorescence optics showing
EGFP expression in the NCC of the ﬁrst and second branchial arches (ba1 and ba2), and in the NCC in the forebrain (fb) and
from frontonasal (fn) region as well as in Wnt1 expressing cells of the midbrain/hindbrain (mb and hb). EGFP-labeled NCC are also
migrating from the CNS between the somites (s) to form the dorsal root ganglia (arrows) at all somitic levels. (Bottom) Transverse
section through the region of the ﬁrst and second branchial arches (ba1 and ba2) (X40) of a 9.5-dpc, two-component Wnt1-Cre/Z/EG
transgenic embryo. Tissue sections were visualized under brightﬁeld (d) and epiﬂuorescence (e) optics. EGFP ﬂuorescence is visible
in peripheral neural crest cells (ncc) and in the dorsal neural tube (dnt).
aRNA was assessed using an Agilent RNA chip and the
Agilent2100Bioanalyzer(AgilentTechnologies,PaloAlto,
Calif).
Quantitativereal-timePCR
cDNA was synthesized from ampliﬁed RNA (aRNA)
with random hexamer primers and Superscript II reverse
transcriptase (Invitrogen Life Technologies, Inc, Carls-
bad, Calif). Quantitative real-time PCR analysis was per-
formed on a TaqMan ABI Prism 7000 Sequence De-
tector System (Applied Biosystems, Foster City, Calif).
Primers and their corresponding ﬂuorescence probes for
each of the genes were designed and synthesized by Ap-
plied Biosystem’s “Assays-by-Design” custom service. In
all cases, both forward and reverse primers were used at
a concentration of 900nM while the concentration of the
probe was 250nM. For the PCR reaction, 1ng of cDNA
template was incubated with 0.2 mM dATP, dCTP, and
dGTP, 0.4mMdUTP ,and0.625 units of AmpliTaq Gold
( A p p l i e dB i o s y s t e m s ,U K )i naﬁ n a lv o l u m eo f2 5µL. Cy-
cling parameters were as follows: 50 ◦Cf o r2m i n u t e sf o r
probeandprimeractivation,95 ◦Cfor10minutesofDN A
strand denaturation, followed by 40 cycles of denatura-
tion at 95 ◦C for 15 seconds each, and ﬁnally, primer
extension at 60 ◦C for 1 minute. Each cDNA sample was
tested in triplicate and mean Ct values are reported. Fur-
ther, for each reaction, a “no template” sample was in-
cluded as a negative control. Raw data were acquired and
processed with ABI Sequence Detector System software,
version 1.0 (Applied Biosystems, UK).
RESULTS AND DISCUSSION
Embryos resulting from the cross between the Wnt-
Cre and Z/EG transgenic mouse lines were dissected at
9.5dpc. A cranial neural-crest-speciﬁc pattern of green
ﬂuorescence was detected in the embryo (Figure 1). Fluo-
rescencewasobservedinthebranchialarches,frontonasal
region, hindbrain, and also in the dorsal root ganglia
between somite borders along the entire length of the
embryo. Since the midbrain-hindbrain region also con-
tains some Wnt-1 expressing non-neural crest EGFP pos-
itive cells, it was essential to remove this region prior
to FACS. The remaining tissue, consisting of the fron-
tonasalregionandtheﬁrstbranchialarch,wastrypsinized
and resuspended in medium containing 5% FBS prior
to ﬂuorescence-activated cell sorting. Representative his-
tograms of pre- (Figure 2a) and post- (Figure 2b)s o r t e d2005:3 (2005) Novel Method to Isolate Pure Neural Crest Cells and Extract RNA 235
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Figure 2. Flow cytometric analysis and isolation of EGFP-
labeled cranial NCC. Cell suspensions were prepared from
the tissue derived from the cranial region, rostral to the sec-
ond branchial arch, of 9.5-dpc EGFP-labeled embryos. Cells
were subjected to ﬂuorescence-activated cell sorting as delin-
eated in the “materials and methods.” Representative histogram
(a) shows total population of gated cells. Representative post-
sorting histogram (b) indicates EGFP-positive neural crest cells
insectorR12.TheEGFP-labeledcellpopulationinR12routinely
constitutes approximately 30% of the total gated cells.
cells indicate that approximately 30% of the total cells
that were sorted were EGFP-positive (Figure 2b,s e es e ct o r
R12). Post-sorting propidium iodide staining of EGFP-
labeled cells indicated cell viability to be 98% (results not
shown), conﬁrming that the mechanistic pressures ex-
erted on cells during FACS had no eﬀect on their viabil-
ity. FACS-isolated cells were plated on chambered glass
slides and allowed to grow for 24 hours at 37 ◦C. Pho-
tomicrographs of FACS-isolated NCC in cell culture, un-
derbrightﬁeld(Figure3a)andepiﬂuorescence(Figure3b)
optics, indicate that the cultures contain a viable, ho-
mogenous population of EGFP-labeled cells that are ca-
pable of attachment to the substratum and subsequent
spreading. These data demonstrate the feasibility of ﬂow-
sortingandsubsequentgrowthincultureofEGFP-labeled
cranial neural crest cells.
RNA was extracted from a corresponding sample of
ﬂow sorted EGFP-positive cranial neural crest cells using
thePicoPureRNAisolationkit.AnalysisoftheRNAonan
Agilent RNA chip demonstrated that the majority of RNA
fragments were between 200 and 2000 nucleotides with
the majority around 550nt (Figure 4) .A tt h ee n do ft w o
rounds of ampliﬁcation, the total RNA yield, as measured
spectrophotometrically, was 229µg. The quality and yield
of ampliﬁed RNA is suﬃcient for microarray analysis
(a)
(b)
Figure 3. FACS-isolated NCC in cell culture. EGFP-labeled cra-
nial NCC were isolated by FACS and established in primary
culture as detailed in the “materials and methods.” Photomi-
crographs of FACS-isolated, EGFP-labeled NCC (24 hour cul-
tures) under brightﬁeld (a) and epiﬂuorescence (b) optics, indi-
cate that the cultures contain a viable, homogenous population
of EGFP-labeled cells. (Magniﬁcation 115X).
using a variety of commercial microarray platforms. To
ensure that this ﬂow sorting method indeed separated
(EGFP) labeled neural crest cells, quantitative RT-PCR
was performed to detect expression of speciﬁc marker
genes of the neural crest. These included Crabp1, Slug,
Dlx5, and Msx1[ 18, 19]. In addition, engrailed 1 (En1)
was included as a negative control and glyceraldehyde-3-
phosphatedehydrogenase(GAPDH)wasutilizedasanin-
ternal control [20, 21]. Results shown in Table 1 are ex-
pressed as Ct values representing the number of cycles
during the exponential phase of ampliﬁcation necessary
to reach a predetermined threshold level of PCR prod-
uct as measured by ﬂuorescence. The Ct values are di-
rectly proportional to the amount of input template, such
that a higher Ct value would indicate a lower copy num-
ber of the gene of interest. The four NCC marker genes
demonstrated signiﬁcant ampliﬁcation when compared
with control reactions lacking reverse transcriptase. The
En1 gene was not ampliﬁed under the same reaction con-
ditions, aﬃrming the speciﬁcity of FACS-captured cranial
NCC from the 9.5dpcembryos.236 Saurabh Singh et al 2005:3 (2005)
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Figure 4. Fragment size proﬁle of ampliﬁed RNA that was extracted from FACS-isolated EGFP-labeled cranial NCC as determined
by electrophoretic separation on an Agilent RNA Biochip. Antisense RNA abundance (ﬂuorescence) is graphed as a function of RNA
fragment size (time of electrophoretic migration, in seconds). The graph (a) represents the fragment size proﬁle from ampliﬁed,
antisense RNA from FACS-isolated EGFP-labeled NCC while the graph (b) represents the fragment size proﬁle of RNA size markers
used as a standard. RNA fragment size (in nucleotides) is denoted adjacent to peaks on the proﬁles. The mRNA proﬁle from the
FACS-isolated NCC demonstrates a signiﬁcant population of fragments in the 200–2000 nucleotide size range.
Table 1. Expression of NCC marker genes by FACS-isolated,
EGFP-labeled NCC.1
Gene Ct value2,3
Msx1 28.60
Crabp1 18.12
Slug 23.75
Dlx5 28.15
GAPDH4 17.69
En15 No ampliﬁcation
1Expression of NCC gene markers was determined using TaqMan
quantitative real-time PCR (QRT-PCR) as detailed in “materials and
methods.”
2NCC cDNA samples were prepared and subjected to QRT-PCR for
each target gene in triplicate; mean Ct values are reported.
3Negative methodological control reactions, which lacked reverse
transcriptase, did not amplify any detectable product.
4GAPDH was utilized as an internal control to normalize gene
expression.
5En1, a negative control gene that is known not to be expressed by NCC.
Data in the present report document the feasibility of
utilizing ﬂuorescence-activated cell sorting to isolate vi-
able EGFP-labeled neural crest cells from a heterogeneous
pool of trypsinized cells derived from murine embryonic
tissue. The present strategy aﬀords the ability to obtain
homogenous populations of murine neural crest in such
a manner as to retain the integrity of proteins, DNA, and
RNA for subsequent biochemical and molecular analysis.
Accordingly, both lineage analysis and molecular/genetic
analyses of the murine embryonic neural crest cells and
t h e i rv a r i o u sd e r i v a t i v e s ,b yt e c h n i q u e ss u c ha sQ R T -
PCR,genemicroarrays,andproteomicsbecomeviableav-
enues of pursuit to further our understanding of these
pluripotent progenitor cells during embryonic develop-
ment.
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